Kurt Wheeler's Net Worth

$201 Million

Who is Kurt Wheeler?

Kurt Wheeler has an estimated net worth of $201 Million. This is based on reported shares across multiple companies, which include TETRALOGIC PHARMACEUTICALS Corp, EnteroMedics Inc, GLOBUS MEDICAL INC, COTHERIX INC, ZOGENIX, INC., ARYx Therapeutics, Inc., Restore Medical, Inc., VIACELL INC, TERCICA INC, BARRIER THERAPEUTICS INC, RIGEL PHARMACEUTICALS INC, Radius Health, Inc., PHARMATHENE, INC, AERIE PHARMACEUTICALS INC, Ophthotech Corp., Oxford Immunotec Global PLC, Sientra, Inc., XCYTE THERAPIES INC, PONIARD PHARMACEUTICALS, INC., KALOBIOS PHARMACEUTICALS INC, Restoration Robotics Inc, Forty Seven, Inc., AVANIR PHARMACEUTICALS, INC., Pharmasset Inc, Zalicus Inc., ACHILLION PHARMACEUTICALS INC, HELICOS BIOSCIENCES CORP, METABASIS THERAPEUTICS INC, Somaxon Pharmaceuticals, Inc., Entasis Therapeutics Holdings Inc., HEMOSENSE INC, Alsius Corp, CRYOCOR INC, AVEO PHARMACEUTICALS INC, CRITICAL THERAPEUTICS INC, AFFYMAX INC, and SENORX INC.

SEC CIK

Kurt Wheeler's CIK is 0001252525

Past Insider Trading and Trends

2007 was Kurt Wheeler's most active year for acquiring shares with 29 total transactions. Kurt Wheeler's most active month to acquire stocks was the month of May. 2004 was Kurt Wheeler's most active year for disposing of shares, totalling 44 transactions. Kurt Wheeler's most active month to dispose stocks was the month of May. 2010 saw Kurt Wheeler paying a total of $28,129,182.13 for 20,745,320 shares, this is the most they've acquired in one year. In 2007 Kurt Wheeler cashed out on 37,109,423 shares for a total of $97,780,150.46, their largest year based on trade value.